Previous Close
$8.34
Day Range
$7.8527 - $8.66
Previous Day Range
$7.4 - $8.4034
Market Cap
$9.1 million USD
Day Vol.
26168
Previous Day Vol.
936488
Currency
USD
Primary Exchange
Nasdaq
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. ...
Community
- 0 posts discussing
0
Watchers
0
Visitors
Recent News
Trending Tickers
Please sign in to view